stella
beta
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease — Stella
Recruiting
Back to Rhabdomyosarcoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Stanford University, Palo Alto, California
St. Jude Children's Research Hospital, Memphis, Tennessee
Cook Children's Medical Center, Fort Worth, Texas
View full record on ClinicalTrials.gov